Stocktoria
ACCENDRA HEALTH INC/VA/ ACH
NYSE · XNYS · stock · Wholesale-Medical, Dental & Hospital Equipment & Supplies · website · IPO 1980-03-17
ACCENDRA HEALTH INC/VA/ financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.8B | $2.7B | $2.6B | $10.0B | $9.8B |
| Gross profit | — | $2.2B | $2.1B | $1.8B | $1.5B |
| R&D expense | — | $13.0M | $13.0M | $12.0M | $12.1M |
| SG&A expense | $1.1B | $1.1B | $1.0B | $1.6B | $1.1B |
| Operating income | $27.5M | -$217.7M | $133.2M | $142.9M | $368.5M |
| Interest expense | $107.2M | $107.6M | $116.8M | $128.9M | $48.1M |
| Income tax | $729,000 | $20.9M | $6.4M | -$11.5M | $55.2M |
| Net income | -$1.1B | -$362.7M | -$41.3M | $22.4M | $221.6M |
| EPS (diluted) | $-14.31 | $-4.73 | $-0.53 | $0.29 | $2.94 |
| Operating cash flow | -$101.8M | $161.5M | $740.7M | $325.0M | $124.2M |
| Free cash flow | -$292.7M | -$8.8M | $568.3M | $166.9M | $83.2M |
| Cash & equivalents | $282.0M | $27.6M | $243.0M | $69.5M | $55.7M |
| Inventory | $74.4M | $67.6M | $1.1B | $1.3B | $1.5B |
| Total assets | $2.5B | $4.7B | $5.1B | $5.4B | $3.5B |
| Total liabilities | $2.9B | $4.1B | $4.2B | $4.4B | $2.6B |
| Shareholders' equity | -$461.0M | $586.4M | $945.3M | $966.7M | $938.5M |
Source: SEC EDGAR filings · CIK 0000075252 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.